Skip to content

    Recently Viewed


      FINAL LEDE- What You Need to Know About Johnson & Johnson's 2019 Second-Quarter Earnings-Q2 2019 earnings

      What you need to know about Johnson & Johnson’s 2019 second-quarter earnings

      Check out this infographic breakdown of the company’s second-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

      Share Article
      share to
      Inset - Quarterly Earnings Ribbon

      This morning, Johnson & Johnson shared its second-quarter performance.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “Our solid second-quarter results can be attributed to the dedication and hard work of our Johnson & Johnson colleagues around the world, who perpetually strive to bring differentiated healthcare solutions to the most pressing unmet medical needs,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “As we remain focused on delivering value to all of our stakeholders, we will continue to optimize our portfolio to ensure we make progress against our long-term strategies. Our results during the first half of this year reaffirm our confidence in our 2019 outlook, and position us well to invest for continued success in the future.”

      For more details about the company’s second-quarter 2019 results, and to read a comment from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.

      2019 Q2 Earnings infographic

      Johnson & Johnson’s 2019 2nd-Quarter Earnings

      Read the earnings press release, which includes full financial details for the second quarter of the year.

      Want to see more company earnings information? Find several years of Johnson & Johnson’s quarterly and full-year results here.

      More from Johnson & Johnson

      Blue latex-gloved hands holding a beaker filled with yellow liquid

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.